Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)

Sinphar Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,905	5,652	5,694	5,560	4,847	5,191
Market Cap Growth	-7.85%	-0.75%	2.41%	14.71%	-6.62%	59.54%
Enterprise Value	6,925	6,596	6,880	6,634	6,118	6,688
Last Close Price	32.60	31.20	30.59	28.98	25.09	26.73
PE Ratio	19.29	18.55	15.18	24.75	-	-
Forward PE	17.43	62.19	62.19	62.19	62.19	62.19
PS Ratio	1.86	1.79	1.92	1.95	1.99	2.17
PB Ratio	1.61	1.59	1.68	1.73	1.58	1.65
P/TBV Ratio	1.78	1.77	1.88	1.96	1.86	2.01
P/FCF Ratio	13.83	16.01	6621.12	19.59	-	2179.26
P/OCF Ratio	9.87	9.52	19.21	13.07	35.76	35.46
EV/Sales Ratio	2.18	2.09	2.32	2.32	2.51	2.80
EV/EBITDA Ratio	11.94	12.22	13.28	14.85	95.71	59.36
EV/EBIT Ratio	20.67	22.20	23.83	33.40	-	-
EV/FCF Ratio	16.21	18.68	7999.47	23.38	-	2807.81
Debt / Equity Ratio	0.51	0.54	0.57	0.60	0.69	0.69
Debt / EBITDA Ratio	3.21	3.52	3.75	4.28	33.06	19.04
Debt / FCF Ratio	4.36	5.39	2261.46	6.74	-	905.50
Asset Turnover	0.50	0.50	0.48	0.46	0.39	0.40
Inventory Turnover	2.37	2.35	2.22	2.17	1.86	1.96
Quick Ratio	1.74	1.30	1.46	1.36	1.22	1.24
Current Ratio	2.54	1.84	2.20	1.92	1.76	1.91
Return on Equity (ROE)	8.05%	8.21%	10.79%	5.22%	-6.59%	-5.44%
Return on Assets (ROA)	3.31%	2.96%	2.90%	2.00%	-1.85%	-1.27%
Return on Capital (ROIC)	3.81%	3.44%	3.45%	2.40%	-2.17%	-1.46%
Return on Capital Employed (ROCE)	6.40%	6.10%	5.70%	4.20%	-	-
Earnings Yield	5.19%	5.39%	6.59%	4.04%	-0.79%	-0.55%
FCF Yield	7.23%	6.25%	0.01%	5.10%	-0.22%	0.05%
Dividend Yield	3.07%	3.21%	3.03%	3.19%	0.74%	0.69%
Payout Ratio	54.68%	55.04%	44.71%	14.93%	-	-
Buyback Yield / Dilution	-0.06%	-0.02%	0.00%	-0.17%	-	0.07%
Total Shareholder Return	2.96%	3.18%	3.03%	3.02%	0.74%	0.77%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.